494 related articles for article (PubMed ID: 20039281)
21. Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma.
Cadili A; Scolyer RA; Brown PT; Dabbs K; Thompson JF
Ann Surg Oncol; 2010 Nov; 17(11):3015-20. PubMed ID: 20552405
[TBL] [Abstract][Full Text] [Related]
22. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?
Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB
Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708
[TBL] [Abstract][Full Text] [Related]
23. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA
Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112
[TBL] [Abstract][Full Text] [Related]
24. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
25. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
[TBL] [Abstract][Full Text] [Related]
28. Completion node dissection in patients with sentinel node-positive melanoma of the head and neck.
Smith VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):591-9. PubMed ID: 22237296
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
30. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
31. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
32. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
[TBL] [Abstract][Full Text] [Related]
35. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
36. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
37. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
39. Influence of sentinel lymph node tumor burden on survival in melanoma.
Francischetto T; Spector N; Neto Rezende JF; de Azevedo Antunes M; de Oliveira Romano S; Small IA; Gil Ferreira C
Ann Surg Oncol; 2010 Apr; 17(4):1152-8. PubMed ID: 20087785
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]